/Lists

Biotech Series B Investors & VC Firms

724 firms in this list, with a median first check of $500K. 165 of them lead rounds. Generated from verified public data and updated continuously.

New Leaf Venture Partners
New YorkSeed–Series B
7 people
Cycad Group LLC
Santa BarbaraSeed–Late Stage
4 people
IAG Capital Partners
CharlestonSeed–Growth
4 people
CLI Ventures
Palo AltoSeed–Late Stage
6 people
Montis Capital
WarsawSeries A–Growth$1.6M – $5.5M
4 people
JJDC
New BrunswickSeed–Series B$500K – $5M
11 people
Sectoral Asset Management
MontrealSeries B–Late Stage
8 people
What If Ventures
FriscoPre-Seed–Late Stage
3 people
Vertex Ventures HC
SingaporeSeed–Growth$500K – $10M
4 people
Neurone Group
LuxembourgSeed–Late Stage
11 people
Vesalius Biocapital Partners
LuxembourgSeed–Growth$11M
5 people
ExSight Ventures
New YorkPre-Seed–Series B
4 people
Pandect Bioventures
WoodsideSeed–Late Stage
10 people
Clal Biotechnology Industries
Tel AvivSeed–Late Stage
8 people
Kendall Capital Partners
BostonSeed–Growth
7 people
Korify Capital
Series A–Series C
6 people
Ming capital
ShenzhenSeed–Series C
6 people
Ono Venture Investment, Inc.
South San FranciscoSeed–Series B
6 people
SBI JI Innovation Advisory Ltd.
Tel Aviv-YafoSeed–Series B
6 people
Sirius Venture Partners GmbH
WiesbadenSeed–Growth$540K – $5.4M
8 people
Vesalius Biocapital III Partners SàRL
ConternSeries B–Late Stage$10.8M
11 people
7thirty
BoulderSeed–Series B$100K – $1M
2 people
Oost NL
ApeldoornSeed–Late Stage$108K – $5.4M
2 people
Mohr Davidow Ventures
San MateoSeed–Late Stage$200K – $4M
7 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.